Viersprong Institute for Studies on Personality Disorders, Halsteren, The Netherlands.
Expertcentre MBT-Nederland, Bergen op Zoom, The Netherlands.
Psychol Med. 2022 Feb;52(3):485-495. doi: 10.1017/S0033291720002123. Epub 2020 Jun 30.
Two types of mentalization-based treatment (MBT), day hospital MBT (MBT-DH) and intensive outpatient MBT (MBT-IOP), have been shown to be effective in treating patients with borderline personality disorder (BPD). This study evaluated trajectories of change in a multi-site trial of MBT-DH and MBT-IOP at 36 months after the start of treatment.
All 114 patients (MBT-DH n = 70, MBT-IOP n = 44) from the original multicentre trial were assessed at 24, 30 and 36 months after the start of treatment. The primary outcome was symptom severity measured with the Brief Symptom Inventory. Secondary outcome measures included borderline symptomatology, personality and interpersonal functioning, quality of life and self-harm. Data were analysed using multilevel modelling and the intention-to-treat principle.
Patients in both MBT-DH and MBT-IOP maintained the substantial improvements made during the intensive treatment phase and showed further gains during follow-up. Across both conditions, 83% of patients improved in terms of symptom severity, and 97% improved on borderline symptomatology. No significant differences were found between MBT-DH and MBT-IOP at 36 months after the start of treatment. However, trajectories of change were different. Whereas patients in MBT-DH showed greater improvement during the intensive treatment phase, patients in MBT-IOP showed greater continuing improvement during follow-up.
Patients in both conditions showed similar large improvements over the course of 36 months, despite large differences in treatment intensity. MBT-DH and MBT-IOP were associated with different trajectories of change. Cost-effectiveness considerations and predictors of differential treatment outcome may further inform optimal treatment selection.
两种基于心理化的治疗(MBT),日间医院 MBT(MBT-DH)和强化门诊 MBT(MBT-IOP),已被证明对治疗边缘型人格障碍(BPD)患者有效。本研究评估了在治疗开始后 36 个月的多地点 MBT-DH 和 MBT-IOP 试验中变化的轨迹。
来自原始多中心试验的所有 114 名患者(MBT-DH n=70,MBT-IOP n=44)在治疗开始后 24、30 和 36 个月时进行评估。主要结局是用简明症状量表测量的症状严重程度。次要结局指标包括边缘症状、人格和人际功能、生活质量和自伤。使用多层次建模和意向治疗原则分析数据。
MBT-DH 和 MBT-IOP 组的患者都维持了强化治疗阶段所取得的显著改善,并在随访期间进一步获益。在两种情况下,83%的患者在症状严重程度方面有所改善,97%的患者在边缘症状方面有所改善。在治疗开始后 36 个月时,MBT-DH 和 MBT-IOP 之间没有发现显著差异。然而,变化的轨迹是不同的。虽然 MBT-DH 组的患者在强化治疗阶段有更大的改善,但 MBT-IOP 组的患者在随访期间有更大的持续改善。
尽管治疗强度存在很大差异,但两种情况下的患者在 36 个月的过程中都显示出类似的大幅改善。MBT-DH 和 MBT-IOP 与不同的变化轨迹相关。成本效益考虑和预测不同的治疗结果可能会进一步为最佳治疗选择提供信息。